NanoVector, Inc.

Location:27624, US
Speaker: Bruce Oberhardt, Ph.D.
Title:President and CSO
Primary Industry:Pharma & Biotech
Executive Summary:Nanovector has developed a unique plant virus nanoparticle drug delivery system which we will commercialize using a two prong strategy. First we will partner with large pharmaceutical companies to deliver oligonucleotides to the cell cytoplasm for RNAi and using our patented two-stage targeting to the cell nucleus for microRNA and gene splicing therapeutics. Secondly, we will use our nanoparticle drug delivery system as a platform to internally develop a family of targeted cancer therapeutics for the $65B/year breast and colon cancer markets. With targeted therapy only cancer cells are killed minimizing the horrendous side effects associated with the current non target free drug treatments. In addition with the Nanovector patented nuclear targeting we are the only company that can defeat the cancer cell’s defenses that leads to multi-drug resistance of current therapies and the only company that can kill the elusive cancer stem cell which is believed to cause new tumor formation. If this belief holds true we have the ability to cure certain categories of cancer. The Nanovector technology is highly sought after by large pharmaceutical companies positioning Nanovector for a huge value appreciation.
Venture is:Seed Level

HIGHLIGHTS

Merck
Corporate Symposium

Harvard OTD
Partner Sponsor

2008 Corporate Presentations

Air Products
Boeing
BP
Cabot
Honda
Kodak
Medtronic
Merck
  • BASF
  • Genzyme
  • Lockheed Martin
  • Sanyo

Event Sponsors

Univalor
AzTE
Jackson Walker

Collocated Events

June 1-5, 2008
Nanotech 2008
Clean Technology 2008
BioNano 2008

Press Sponsor

Business Wire

Commercialization Partner

BusinessWeek

Media Sponsors

(joint with Nanotech 2008) Nature
Science
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network
piribo

 

“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
 
Matthew Laudon, Co-Founder and Director of TechConnect